Prescribing Information
- Business
Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients
LACHEN, Switzerland: Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing…
Read More »